Annual Revenue
$50.16 M
-$3.71 M-6.90%
30 April 2024
Summary:
Champions Oncology annual revenue is currently $50.16 million, with the most recent change of -$3.71 million (-6.90%) on 30 April 2024. During the last 3 years, it has risen by +$9.12 million (+22.21%). CSBR annual revenue is now -6.90% below its all-time high of $53.87 million, reached on 30 April 2023.CSBR Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$14.06 M
+$59.00 K+0.42%
31 July 2024
Summary:
Champions Oncology quarterly revenue is currently $14.06 million, with the most recent change of +$59.00 thousand (+0.42%) on 31 July 2024. Over the past year, it has increased by +$2.49 million (+21.50%). CSBR quarterly revenue is now -1.54% below its all-time high of $14.28 million, reached on 31 October 2022.CSBR Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$51.66 M
+$1.50 M+2.99%
31 July 2024
Summary:
Champions Oncology TTM revenue is currently $51.66 million, with the most recent change of +$1.50 million (+2.99%) on 31 July 2024. Over the past year, it has increased by +$1.68 million (+3.36%). CSBR TTM revenue is now -4.51% below its all-time high of $54.10 million, reached on 31 October 2022.CSBR TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSBR Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -6.9% | +21.5% | +3.4% |
| 3 y3 years | +22.2% | +19.3% | +16.3% |
| 5 y5 years | +85.3% | +84.4% | +81.2% |
CSBR Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -6.9% | +22.2% | -1.5% | +21.5% | -4.5% | +16.3% |
| 5 y | 5 years | -6.9% | +85.3% | -1.5% | +84.4% | -4.5% | +81.2% |
| alltime | all time | -6.9% | +3482.5% | -1.5% | +6146.6% | -4.5% | >+9999.0% |
Champions Oncology Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2024 | - | $14.06 M(+0.4%) | $51.66 M(+3.0%) |
| Apr 2024 | $50.16 M(-6.9%) | $14.00 M(+16.5%) | $50.16 M(+1.9%) |
| Jan 2024 | - | $12.02 M(+3.9%) | $49.22 M(-1.5%) |
| Oct 2023 | - | $11.57 M(-7.9%) | $49.98 M(-5.1%) |
| July 2023 | - | $12.56 M(-3.9%) | $52.69 M(-2.2%) |
| Apr 2023 | $53.87 M(+9.7%) | $13.07 M(+2.3%) | $53.87 M(+0.4%) |
| Jan 2023 | - | $12.77 M(-10.6%) | $53.68 M(-0.8%) |
| Oct 2022 | - | $14.28 M(+3.9%) | $54.10 M(+4.8%) |
| July 2022 | - | $13.74 M(+6.7%) | $51.60 M(+5.1%) |
| Apr 2022 | $49.11 M(+19.7%) | $12.88 M(-2.4%) | $49.11 M(+4.9%) |
| Jan 2022 | - | $13.19 M(+11.9%) | $46.80 M(+5.4%) |
| Oct 2021 | - | $11.79 M(+4.7%) | $44.41 M(+3.9%) |
| July 2021 | - | $11.25 M(+6.5%) | $42.75 M(+4.2%) |
| Apr 2021 | $41.04 M(+27.8%) | $10.56 M(-2.3%) | $41.04 M(+4.6%) |
| Jan 2021 | - | $10.81 M(+6.9%) | $39.22 M(+4.8%) |
| Oct 2020 | - | $10.12 M(+6.0%) | $37.42 M(+7.1%) |
| July 2020 | - | $9.55 M(+9.1%) | $34.93 M(+8.7%) |
| Apr 2020 | $32.12 M(+18.7%) | $8.75 M(-2.9%) | $32.12 M(+3.3%) |
| Jan 2020 | - | $9.01 M(+18.2%) | $31.09 M(+9.1%) |
| Oct 2019 | - | $7.63 M(+13.2%) | $28.51 M(+3.4%) |
| July 2019 | - | $6.74 M(-12.7%) | $27.58 M(+1.9%) |
| Apr 2019 | $27.07 M(+33.7%) | $7.72 M(+20.0%) | $27.07 M(+11.5%) |
| Jan 2019 | - | $6.43 M(-3.9%) | $24.27 M(+5.9%) |
| Oct 2018 | - | $6.69 M(+7.5%) | $22.92 M(+7.0%) |
| July 2018 | - | $6.22 M(+26.5%) | $21.43 M(+5.9%) |
| Apr 2018 | $20.24 M(+31.3%) | $4.92 M(-3.1%) | $20.24 M(+6.3%) |
| Jan 2018 | - | $5.08 M(-2.3%) | $19.04 M(+8.7%) |
| Oct 2017 | - | $5.20 M(+3.4%) | $17.52 M(+4.4%) |
| July 2017 | - | $5.03 M(+35.3%) | $16.77 M(+8.8%) |
| Apr 2017 | $15.41 M(+37.8%) | $3.72 M(+4.3%) | $15.41 M(+6.1%) |
| Jan 2017 | - | $3.56 M(-20.0%) | $14.53 M(+7.5%) |
| Oct 2016 | - | $4.46 M(+21.4%) | $13.52 M(+12.4%) |
| July 2016 | - | $3.67 M(+29.4%) | $12.03 M(+7.6%) |
| Apr 2016 | $11.18 M(+26.2%) | $2.84 M(+11.2%) | $11.18 M(-3.5%) |
| Jan 2016 | - | $2.55 M(-14.1%) | $11.59 M(+6.7%) |
| Oct 2015 | - | $2.97 M(+5.3%) | $10.86 M(+11.1%) |
| July 2015 | - | $2.82 M(-12.9%) | $9.77 M(+10.3%) |
| Apr 2015 | $8.86 M(-23.3%) | $3.24 M(+77.2%) | $8.86 M(+9.7%) |
| Jan 2015 | - | $1.83 M(-2.8%) | $8.08 M(-18.7%) |
| Oct 2014 | - | $1.88 M(-1.6%) | $9.94 M(-4.8%) |
| July 2014 | - | $1.91 M(-22.2%) | $10.44 M(-9.6%) |
| Apr 2014 | $11.55 M | $2.46 M(-33.4%) | $11.55 M(+5.6%) |
| Jan 2014 | - | $3.69 M(+54.8%) | $10.94 M(+7.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2013 | - | $2.38 M(-21.1%) | $10.16 M(+10.0%) |
| July 2013 | - | $3.02 M(+64.0%) | $9.24 M(+11.0%) |
| Apr 2013 | $8.32 M(+16.4%) | $1.84 M(-36.9%) | $8.32 M(+5.9%) |
| Jan 2013 | - | $2.92 M(+100.1%) | $7.86 M(+7.1%) |
| Oct 2012 | - | $1.46 M(-30.8%) | $7.34 M(-3.7%) |
| July 2012 | - | $2.11 M(+52.5%) | $7.62 M(+6.6%) |
| Apr 2012 | $7.15 M(+3.9%) | $1.38 M(-42.4%) | $7.15 M(-2.2%) |
| Jan 2012 | - | $2.40 M(+37.6%) | $7.32 M(-5.3%) |
| Oct 2011 | - | $1.74 M(+6.5%) | $7.72 M(+11.7%) |
| July 2011 | - | $1.63 M(+5.8%) | $6.92 M(+0.5%) |
| Apr 2011 | $6.88 M(+40.6%) | $1.54 M(-45.0%) | $6.88 M(-4.9%) |
| Jan 2011 | - | $2.81 M(+200.6%) | $7.24 M(+39.9%) |
| Oct 2010 | - | $933.00 K(-41.7%) | $5.17 M(-6.4%) |
| July 2010 | - | $1.60 M(-15.8%) | $5.53 M(+13.0%) |
| Apr 2010 | $4.89 M(+31.9%) | $1.90 M(+156.1%) | $4.89 M(+22.3%) |
| Jan 2010 | - | $742.00 K(-42.4%) | $4.00 M(-5.7%) |
| Oct 2009 | - | $1.29 M(+34.0%) | $4.24 M(+6.1%) |
| July 2009 | - | $962.00 K(-4.7%) | $4.00 M(+7.8%) |
| Apr 2009 | $3.71 M(+165.0%) | $1.01 M(+2.5%) | $3.71 M(+26.8%) |
| Jan 2009 | - | $984.00 K(-5.8%) | $2.93 M(+2.1%) |
| Oct 2008 | - | $1.04 M(+55.2%) | $2.87 M(+57.3%) |
| July 2008 | - | $673.00 K(+199.0%) | $1.82 M(+30.2%) |
| Apr 2008 | $1.40 M(-30.0%) | $225.10 K(-75.7%) | $1.40 M(+19.2%) |
| Jan 2008 | - | $924.90 K(+270.0%) | $1.17 M(+370.0%) |
| July 2007 | - | $250.00 K(-53.1%) | $250.00 K(-87.5%) |
| Apr 2004 | $2.00 M(-0.4%) | $533.00 K(+15.3%) | $2.00 M(+2.2%) |
| Jan 2004 | - | $462.10 K(+0.3%) | $1.96 M(+0.6%) |
| Oct 2003 | - | $460.90 K(-15.2%) | $1.94 M(-4.5%) |
| July 2003 | - | $543.20 K(+10.8%) | $2.04 M(+1.2%) |
| Apr 2003 | $2.01 M(-5.7%) | $490.20 K(+8.8%) | $2.01 M(-2.6%) |
| Jan 2003 | - | $450.60 K(-18.6%) | $2.07 M(-3.1%) |
| Oct 2002 | - | $553.50 K(+6.8%) | $2.13 M(+1.2%) |
| July 2002 | - | $518.10 K(-4.6%) | $2.11 M(-1.7%) |
| Apr 2002 | $2.13 M(-2.2%) | $543.10 K(+5.3%) | $2.14 M(-4.4%) |
| Jan 2002 | - | $515.80 K(-2.3%) | $2.24 M(+2.1%) |
| Oct 2001 | - | $528.10 K(-4.8%) | $2.19 M(+2.7%) |
| July 2001 | - | $554.90 K(-13.4%) | $2.14 M(-2.7%) |
| Apr 2001 | $2.18 M(-0.0%) | $640.60 K(+36.2%) | $2.19 M(+3.0%) |
| Jan 2001 | - | $470.30 K(+0.0%) | $2.13 M(-1.4%) |
| Oct 2000 | - | $470.20 K(-23.3%) | $2.16 M(+27.8%) |
| July 2000 | - | $613.40 K(+6.4%) | $1.69 M(+57.0%) |
| Apr 2000 | $2.18 M | $576.60 K(+15.3%) | $1.08 M(+115.3%) |
| Jan 2000 | - | $500.00 K | $500.00 K |
FAQ
- What is Champions Oncology annual revenue?
- What is the all time high annual revenue for Champions Oncology?
- What is Champions Oncology annual revenue year-on-year change?
- What is Champions Oncology quarterly revenue?
- What is the all time high quarterly revenue for Champions Oncology?
- What is Champions Oncology quarterly revenue year-on-year change?
- What is Champions Oncology TTM revenue?
- What is the all time high TTM revenue for Champions Oncology?
- What is Champions Oncology TTM revenue year-on-year change?
What is Champions Oncology annual revenue?
The current annual revenue of CSBR is $50.16 M
What is the all time high annual revenue for Champions Oncology?
Champions Oncology all-time high annual revenue is $53.87 M
What is Champions Oncology annual revenue year-on-year change?
Over the past year, CSBR annual revenue has changed by -$3.71 M (-6.90%)
What is Champions Oncology quarterly revenue?
The current quarterly revenue of CSBR is $14.06 M
What is the all time high quarterly revenue for Champions Oncology?
Champions Oncology all-time high quarterly revenue is $14.28 M
What is Champions Oncology quarterly revenue year-on-year change?
Over the past year, CSBR quarterly revenue has changed by +$2.49 M (+21.50%)
What is Champions Oncology TTM revenue?
The current TTM revenue of CSBR is $51.66 M
What is the all time high TTM revenue for Champions Oncology?
Champions Oncology all-time high TTM revenue is $54.10 M
What is Champions Oncology TTM revenue year-on-year change?
Over the past year, CSBR TTM revenue has changed by +$1.68 M (+3.36%)